Berman Capital Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$22K Buy
349
+45
+15% +$3.43K ﹤0.01% 941
2021
Q2
$27K Buy
304
+137
+82% +$10.9K ﹤0.01% 791
2021
Q1
$11K Buy
+167
New +$13K ﹤0.01% 997

Other funds holding CDNA

Berman Capital Advisors's CDNA Position: Q3 2021 in Review

Berman Capital Advisors increased its CareDx (CDNA) stake by 15% in Q3 2021, buying an estimated $3.43K and bringing the position to 349 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #941.

Berman Capital Advisors first reported a position in CDNA in Q1 2021 and has held it in 3 quarters since. The position peaked at $27K in Q2 2021. 260 funds tracked by Wall St. Rank hold CDNA as of Q3 2021.

  • Berman Capital Advisors held 349 shares of CareDx worth $22K as of Q3 2021.
  • Berman Capital Advisors bought 45 CareDx shares in Q3 2021, an estimated $3.43K.
  • CareDx made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #941 holding.
  • Berman Capital Advisors first reported a position in CareDx in Q1 2021 and has held it in 3 quarters since.
  • Berman Capital Advisors's CareDx position peaked at $27K in Q2 2021.
  • 260 funds tracked by Wall St. Rank held CareDx as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.